Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria by Kabyemela, Edward R et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Malaria Journal
Open Access Research
Maternal peripheral blood level of IL-10 as a marker for 
inflammatory placental malaria
Edward R Kabyemela†1,2, Atis Muehlenbachs†1,3, Michal Fried1,3, 
Jonathan D Kurtis4, Theonest K Mutabingwa1,5 and Patrick E Duffy*1,3
Address: 1Mother Offspring Malaria Studies (MOMS) Project, Seattle Biomedical Research Institute, Seattle WA 98109, and Muheza Designated 
District Hospital, Muheza, Tanzania, 2Tumaini University, Moshi, Tanzania, 3University of Washington, Seattle WA 98195, USA, 4Brown 
University, Providence, RI, USA and 5National Institute for Medical Research, Dar es salaam, Tanzania
Email: Edward R Kabyemela - earkabyemela@yahoo.com; Atis Muehlenbachs - atis.muehlenbachs@sbri.org; 
Michal Fried - michal.fried@sbri.org; Jonathan D Kurtis - Jonathan_Kurtis@brown.edu; Theonest K Mutabingwa - tk.bingwa@yahoo.com; 
Patrick E Duffy* - patrick.duffy@sbri.org
* Corresponding author    †Equal contributors
Abstract
Background: Placental malaria (PM) is an important cause of maternal and foetal mortality in
tropical areas, and severe sequelae and mortality are related to inflammation in the placenta.
Diagnosis is difficult because PM is often asymptomatic, peripheral blood smear examination
detects parasitemia as few as half of PM cases, and no peripheral markers have been validated for
placental inflammation.
Methods: In a cohort of Tanzanian parturients, PM was determined by placental blood smears and
placental inflammation was assessed by histology and TNF mRNA levels. Maternal peripheral blood
levels of several immune mediators previously implicated in PM pathogenesis, as well as ferritin and
leptin were measured. The relationship between the levels of these soluble factors to PM and
placental inflammation was examined.
Results: Peripheral levels of TNF, TNF-RI, TNF-RII, IL-1, IL-10, and ferritin were elevated during
PM, whereas levels of IFN-γ, IL-4, IL-5 and IL-6 were unchanged and levels of leptin were decreased.
In receiver operating characteristic curve analysis, IL-10 had the greatest area under the curve, and
would provide a sensitivity of 60% with a false positive rate of 10%. At a cut off level of 15 pg/mL,
IL-10 would detect PM with a sensitivity of 79.5% and a specificity of 84.3%. IL-10 levels correlated
with placental inflammatory cells and placental TNF mRNA levels in first time mothers.
Conclusion: These data suggest that IL-10 may have utility as a biomarker for inflammatory PM in
research studies, but that additional biomarkers may be required to improve clinical diagnosis and
management of malaria during pregnancy.
Background
Placental malaria (PM) due to Plasmodium falciparum is a
major cause of mortality for mothers and their offspring,
and is most frequent and severe during first pregnancies
[1]. PM is caused by parasite-infected erythrocytes that
bind to chondroitin sulfate A (CSA) and sequester in the
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placenta [2]. In histologic studies, PM can appear as an
acute condition with little to no inflammation, or as a
chronic disorder with sometimes heavy inflammation
and deposition of parasite haemozoin (also called pig-
ment) [3]. Chronic inflammatory PM has been most
closely related to poor maternal and foetal outcomes in
earlier studies [4]. In areas of stable malaria transmission,
first time mothers often develop chronic PM, with inflam-
matory infiltrates and elevated Type 1 cytokines in the pla-
centa [4,5].
Antenatal diagnosis of PM by Giemsa-stained blood
smears fails to identify a substantial proportion of PM
cases [6], possibly as many as half [1] and no tools exist
that can predict poor pregnancy outcomes. PCR-based
detection of P. falciparum DNA in peripheral blood is fre-
quently positive when peripheral blood smear is negative.
However, PCR can detect dead parasites, free parasite
DNA, or DNA in phagocytic cells, and PCR-detection is
not associated with pregnancy outcomes [6]. Antigen cap-
ture tests show promise, but they yield information only
on parasitaemia and not inflammation [7]. A recent study
from Kenya reported an association between plasma urok-
inase receptor levels measured at delivery and low birth
weight in maternal malaria [8], suggesting that host
biomarkers may be useful for discriminating women
likely to experience poor outcomes from other women.
Peripheral biomarkers of placental inflammation may be
of particular value, since this condition is related to poor
outcomes. In the present study peripheral blood levels of
several immune mediators and other proteins in a cohort
of Tanzanian women was examined at the time of deliv-
ery, and their associations with PM and placental inflam-
mation was determined.
Methods
Clinical procedures
Placental samples, peripheral blood and clinical informa-
tion were provided by Tanzanian women aged 18 to 45
years delivering at the Muheza Designated District Hospi-
tal, Muheza, Tanga region, in an area of intense malaria
transmission. These women were participating in a birth
cohort study known locally as the Mother-Offspring
Malaria Studies (MOMS) Project. Women signed an
informed consent form before joining the study, and
women with known HIV or HIV-related sequelae in their
offspring were excluded. Routine microbiological testing
for other infectious diseases was not performed at the
study site. Clinical information was collected by project
nurses and assistant medical officers on standardized
forms. Study procedures involving human subjects were
approved by the International Clinical Studies Review
Committee of the Division of Microbiology and Infec-
tious Diseases at the US National Institutes of Health, and
ethical clearance was obtained from the Institutional
Review Boards of Seattle Biomedical Research Institute
and the National Institute for Medical Research in Tanza-
nia.
Peripheral blood was collected in citrate phosphate dex-
trose around the time of delivery, and plasma was sepa-
rated and frozen at -80°C. The placenta was collected at
delivery, and a full thickness biopsy from the middle third
of the placental disc was taken. Tissue was fresh frozen in
liquid nitrogen and stored at -80°C. Placental blood sam-
ples were obtained by manual compression of the placen-
tal tissue in a grinder. Placental parasitaemia was defined
as the identification of any parasites in a placental blood
slide by microscopy. Thick and thin smears were pre-
pared; thin smears were fixed with methanol. Blood slides
were stained for 10 minutes in 10% Giemsa, washed in
tap water, air-dried, then examined using light micros-
copy at 1000 × magnification. Ten thousand red cells were
examined in the thin smear before concluding that a pla-
cental blood slide was negative.
Laboratory procedures
Plasma levels of cytokines, cytokine receptors, ferritin and
leptin were analyzed using a multiplexed, bead-based
platform (BioPlex®, BioRad, Irvine, CA) and custom-made
assay kits as previously described [9]. Detection limits for
these assays were as follows: TNF 0.10 pg/ml, TNF recep-
tor (R) I 1.58 pg/ml, TNF-RII 0.21 pg/ml, IFN-γ 0.04 pg/
ml, IL-1 0.01 pg/ml, IL-4 0.30 pg/ml, IL-5 0.02 pg/ml, IL-
6 0.45 pg/ml, IL-10 0.02 pg/ml, ferritin 0.07 ng/ml, and
leptin 1.28 pg/ml. Levels of soluble factors were adjusted
to account for dilution in anticoagulant at the time of
sample collection. For each plasma sample, all analytes
were assayed in a single day, thus eliminating freeze/thaw
cycles.
For histologic analysis, PM-positive tissue was selected
and 5 mm cryosections of placental tissue were fixed in
methanol and stained with Giemsa. Sections were
assessed by examining greater than ninety 600 × fields per
section. Immune infiltrates within the intervillous spaces
were qualitatively scored as (-) for none or very few
inflammatory cells present, (+) for inflammatory cells
present. Histological analysis was performed by a single
observer (A.M.).
Quantitative PCR was performed as described elsewhere
[10]. Briefly total RNA was extracted from frozen cryosec-
tions using RNeasy minikits (Qiagen) and cDNA was syn-
thesized using Superscript III enzyme (Invitrogen) and
anchored oligodT20 primers. Real-time PCR was per-
formed in duplicate using SYBR green master mix and an
ABI Prism 7000 or 7500 (Applied Biosystems). Threshold
cycles (CT) were calculated and normalized to CT of KRT7
(a gene expressed by trophoblasts and not by inflamma-Malaria Journal 2008, 7:26 http://www.malariajournal.com/content/7/1/26
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tory cells). Data are presented as fold-difference from con-
trol gene, calculated by 2(control CT-gene CT). The
oligonucleotide primers used for PCR reactions included:
TNF Forward CACGCTCTTCTGCCTGCT; TNF-α Reverse
CAGCTTGAGGGTTTGCTACA; KRT7 forward: GGCTGA-
GATCGACAACATCA; KRT7 reverse: CTTGGCACGAG-
CATCCTT.
Statistical analysis
Student's t-test was used for the analysis of maternal age
and birth weight within primigravid (first pregnancy) and
multigravid (second and later pregnancy) groups. Mann-
Whitney test was used to examine cytokine levels. Linear
regression coefficients were calculated using simple
regression analysis. Receiver operating characteristic
(ROC) curve and area under the curve (AUC) analyses
were performed with IL-10 and other soluble factors levels
as continuous variables using JROCFIT and JLABROC4
algorithms that are available online at the URL [11]. Sen-
sitivities and specificities of elevated IL-10 to detect PM
were calculated at specific cutoff levels of 10 pg/ml, 15 pg/
ml or 35 pg/ml. Other analyses were performed using
Statview 5.0.1 (SAS Institute, Cary, North Carolina,
United States).
Results
Peripheral plasma samples used for these studies were
provided by 660 women delivering singleton live-born
babies in Muheza, Tanzania. Clinical data are shown in
Table 1. PM+ multigravid women were younger than PM-
multigravid women, and birthweight was significantly
lower in PM+ deliveries compared to PM- deliveries in
both gravidity groups.
Peripheral levels of cytokines, leptin and ferritin vary 
during PM
Comparison of concentrations of cytokines and other sol-
uble factors in maternal peripheral blood stratified for PM
and parity is shown in Table 2. PM significantly increased
peripheral levels of TNF, TNF-RII, IL-10 and ferritin in
women of both parities. Peripheral levels of TNF-RI and
IL-1 significantly increased while levels of leptin signifi-
cantly decreased in primigravid but not multigravid
women during PM. The levels of other soluble factors
were similar between PM- and PM+ women.
Peripheral IL-10 levels are markers of PM and placental 
inflammation
The soluble factors that were significantly elevated in
peripheral blood during PM were analyzed by ROC curve
analysis to determine their utility as biomarkers to detect
PM (Table 3). IL-10 had the greatest area under the curve
(AUC) at 0.83 in first time mothers and 0.82 for all moth-
ers, indicating the highest sensitivity and specificity. The
ROC curve for IL-10 in first time mothers is shown in Fig-
ure 1. Using an IL-10 cutoff for a false positive rate of 10%
would yield a sensitivity of 60%, whereas a cut off for sen-
sitivity of 90% would yield a false positive rate of 50%.
Ferritin and TNF-RII had AUC values greater than 0.75 in
first time mothers. Derived values, resulting from the
combination by summation or addition of IL-10 with
either ferritin or TNF-RII provided no improvement in
sensitivity and specificity (data not shown).
The ability of IL-10 elevations above various threshold
values to discriminate infected from uninfected women
was examined (Table 4). An IL-10 cutoff level of 15 pg/mL
yielded values above 75% for both parameters. Peripheral
IL-10 levels were specifically elevated in first time mothers
who had placental inflammation by histology (Figure 2).
Further, peripheral IL-10 levels correlated significantly
with placental TNF mRNA (Figure 3).
Discussion
Peripheral blood smear analysis has low sensitivity to
detect PM. PCR based and antigen capture tests for the
diagnosis of PM have increased sensitivity but cannot
detect inflammation, which is related to poor pregnancy
outcomes. This study suggests that peripheral IL-10 levels
may be a useful tool to identify women with inflamma-
tory PM and therefore those likely to have poor pregnancy
outcomes. Using a cut-off level of 15 pg/mL, IL-10 levels
would detect PM with a sensitivity of 79.5% and specifi-
city of 84.3%. IL-10 may have utility in longitudinal stud-
ies, examining the burden of malaria over gestation, when
the placenta is not available for microscopic analysis.
Future studies should measure IL-10 levels throughout
gestation to assess relationships to antenatal parasitemia
and to pregnancy outcomes.
Table 1: Characteristics of the study population. *
Primigravidae Multigravidae
Characteristic PM- (n = 166) PM+ (n = 39) P PM- (n = 415) PM+ (n = 40) P
Maternal age in years (Mean; SD) 20.6 (3.3) 19.7 (1.9) 0.0964 28.9 (5.9) 25.7 (4.4) 0.0008
Birth weight in kg (Mean; SD) 3.10 (0.43) 2.83 (0.42) 0.001 3.25 (0.386) 3.04 (0.36) 0.0014
*Data presented are Mean (SD).Malaria Journal 2008, 7:26 http://www.malariajournal.com/content/7/1/26
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IL-10 is a key cytokine both in protection and immunopa-
thology during malaria. High levels of IL-10 observed dur-
ing malarial episodes may be beneficial by reducing the
inflammatory response, but may be detrimental by
decreasing antiparasitic cellular immune responses. IL-10
is an anti-inflammatory cytokine that acts in part by
blocking monocyte/macrophage production of inflam-
matory cytokines such as IL-6, TNF, and IL-l [12]. Animal
studies have suggested that IL-10 may play a regulatory
role during parasitic infection that modulates susceptibil-
ity. In particular, IL-10 inhibits the microbicidal activity of
IFN-γ-treated macrophages against intracellular parasites
such as Toxoplasma gondii [13], Trypanosoma cruzi [14] and
Leishmania major [15] and the killing of extracellular Schis-
tosoma mansoni schistosomulas [16]. These effects may
result from decreased production of the toxic nitrogen
oxide metabolites[17].
The blood stages of P. falciparum are also cleared by
phagocytosis and killed by oxidative products of nitric
oxide released by macrophages [18]. IL-10 has been previ-
ously observed to be elevated during malarial episodes in
non-pregnant [19,20] and pregnant individuals [21].
Both increased and decreased levels of IL-10 have been
associated with poor malaria outcomes. Low levels of IL-
10 or low IL-10 to TNF ratios were associated with severe
malarial anemia in African children [22,23] while high IL
-10 levels were associated with reduced ability to elimi-
nate malaria parasitaemia in Tanzanian children [24].
PM results from the accumulation of parasites that bind to
CSA in the intervillous spaces of the placenta [2,25]. In
response to the sequestered mass of parasites, inflamma-
tory cells infiltrate the intervillous spaces This inflamma-
tory infiltrate can be massive, and prominently features
monocytes/macrophages. In vitro data suggests these cells
Receiver operator curve for peripheral IL-10 levels in first  time mothers to detect PM Figure 1
Receiver operator curve for peripheral IL-10 levels in first 
time mothers to detect PM. Solid line is the best fit curve; 
dashed lines show the 95% confidence intervals.
Table 3: Area under the Receiver Operator Characteristic 
(ROC) curve to detect PM.*
Soluble factor All gravidities Primigravidae
TNF 0.690 0.731
TNF- RI 0.635 0.694
TNF- RII 0.731 0.752
IL-1 0.608 0.658
IL-10 0.815 0.830
Ferritin 0.733 0.759
*Only cytokines and other soluble factors significantly elevated during 
PM are shown.
Table 2: Peripheral levels of cytokines and other soluble factors stratified by parity and PM status.*
Primigravidae Multigravidae
Factor PM- (n = 166) PM+ (n = 39) P PM- (n = 415) PM+ (n = 40) P
TNF 22.9 [8.3–46.7] 62.1 [26.3–127.5] <0.0001 18.7 [8.70–37.9] 57.7 [23.8–84.7] 0.0002
TNF- RI 948 [550–1411] 1374 [851–2290] 0.0003 812 [481–1249] 1004 [517–1580] 0.0978
TNF- RII 186 [0–494] 673 [260–1425] <0.0001 190 [0–403] 590 [129–959] <0.0001
IL-1 2.28 [0.72–4.36] 5.05 [1.70–11.3] 0.0018 2.06 [0.73–4.46] 3.06 [0.32–7.36] 0.1409
IL-4 0.0 [0.0-0.0] 0.0 [0.0-0.0] 0.7676 0.0 [0.0-0.0] 0.0 [0.0-0.0] 0.9054
IL-5 1.96 [0.39–4.21] 1.76 [0.12–3.32] 0.4215 2.09 [0.39–4.09] 1.90 [0.89–5.89] 0.3158
IL-6 18.4 [9.26–37.6] 29.3 [15.0–42.5] 0.083 13.1 [3.75–29.5] 13.2 [8.83–19.2] 0.7618
IL-10 5.69 [3.28–11.3] 23.4 [15.1–62.7] <0.0001 6.12 [2.91–11.6] 22.2 [13.9–40.3] <0.0001
IFN-γ 0.0 [0.0-0.0] 0.0 [0.0–3.67] 0.5083 0.0 [0.0-0.0] 0.0 [0.0-0.0] 0.6607
Leptin 2404 [973–6218] 1029 [658–4115] 0.0245 2161 [1014–5293] 1490 [452–5052] 0.3444
Ferritin 14.0 [8.00–32.4] 62.7 [20.8–144.8] <0.0001 11.6 [6.7–25.9] 40.4 [19.3–82.0] <0.0001
*Data are presented as median [interquartile ranges]. P-values were calculated by Mann-Whitney test.Malaria Journal 2008, 7:26 http://www.malariajournal.com/content/7/1/26
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are the principal source of IL-10 [21]. In Kenyan children,
high levels of peripheral blood IL-10 were positively cor-
related with binding of infected red blood cells to CD36
[26], but the relevance of this observation to malaria
pathogenesis is unknown, and we find that levels of IL-10
also increase when CSA-binding parasites are the major
parasite form causing infection. Placental levels of TNF
increase during PM [5,21,27] and TNF gene expression is
specifically related to placental inflammation [10].
Increased placental blood levels of TNF are related to poor
outcomes for both the mother and her newborn [5,27]. In
the present study, placental TNF mRNA positively corre-
lated to peripheral blood IL-10 levels in first-time moth-
ers, strengthening the association between peripheral IL-
10 levels and placental inflammation.
The present data indicate that peripheral ferritin levels are
also elevated during PM. Ferritin is a positive acute phase
protein and is known to increase during infection and
injury. In non-pregnant individuals, ferritin levels
increase during both asymptomatic and symptomatic
malaria, and the highest levels have been recorded in indi-
viduals with severe disease [28]. Serum ferritin may also
increase in the presence of subclinical infection [29]. Dur-
ing the acute phase response, inflammatory cytokines
such as IL-1β increase the synthesis of both heavy and
light subunits of ferritin [30]. In this Tanzanian cohort,
PM was associated with elevated levels of IL-1 and TNF in
maternal peripheral blood, particularly among first time
mothers who are most likely to experience placental
inflammation. Ferritin is widely used for determining iron
deficiency anemia in industrialized countries, and there-
fore has the advantage of existing diagnostic platforms.
For this reason, ferritin should also be evaluated in pro-
spective studies as a cost-effective antenatal assay for
screening inflammatory PM and poor pregnancy out-
comes in tropical countries.
Conclusion
In summary, these data suggest that the peripheral IL-10
level may be useful as a biomarker of inflammation due
to PM. Future studies should measure antenatal levels of
IL-10, and assess its relationship to parasitemia and preg-
nancy outcomes, and its utility for monitoring interven-
tional trials. The sensitivity and specificity of peripheral
IL-10 levels at delivery suggest that they may not be suffi-
cient to be used clinically as diagnostic tools. Additional
biomarkers of PM, placental inflammation and PM-
related poor outcomes are needed to improve the clinical
management of this major public health problem.
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